Author response for 'Efficacy and Safety of Janagliflozin Monotherapy in Chinese Patients with Type 2 Diabetes Mellitus Inadequately Controlled on Diet and Exercise: A Multicenter, Randomized, Double‐blind, Placebo‐controlled, Phase 3 Trial'
Autor: | null Linong Ji, null Xiaozhen Jiang, null Qingshun Hao, null Zhifeng Cheng, null Kun Wang, null Shuguang Pang, null Meiying Liu, null Yushan Guo, null Xiaowen Chen, null Xiuhai Su, null Tao Ning, null Jie Liu, null Fang Bian, null Yulan Li, null Zhinong Zhang, null Weihong Song, null Jingfang Sun |
---|---|
Rok vydání: | 2022 |
DOI: | 10.1111/dom.14971/v3/response1 |
Databáze: | OpenAIRE |
Externí odkaz: |